1 Item 1A Risk Factors 18 Item 1B Unresolved Staff Comments 50 Item 1C Cybersecurity Risk Management and Strategy 50 Item 2 Properties 51 Item 3 Legal Proceedings 52 Item 4 Mine Safety Disclosures 54 Part II 55 Item 5 Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 55 Item 6 Selected Financial Data 55 Item 7 Managements Discussion and Analysis of Financial Condition and Results Of Operations 55 Item 7A Quantitative and Qualitative Discl...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-09-29 | 2025-06-30 | 0001731122-25-001316 | EDGAR | 73K words |
| 2024-10-10 | 2024-06-30 | 0001731122-24-001578 | EDGAR | — |
| 2023-10-02 | 2023-06-30 | 0001731122-23-001770 | EDGAR | — |
| 2023-02-27 | 2022-06-30 | 0001731122-23-000271 | EDGAR | — |
| 2021-09-24 | 2021-06-30 | 0001731122-21-001565 | EDGAR | — |
| 2020-09-23 | 2020-06-30 | 0001731122-20-000975 | EDGAR | — |
| 2019-09-30 | 2019-06-30 | 0001731122-19-000575 | EDGAR | — |
| 2018-10-01 | 2018-06-30 | 0001731122-18-000094 | EDGAR | — |
| 2017-09-29 | 2017-06-30 | 0001213900-17-010130 | EDGAR | — |
| 2016-09-28 | 2016-06-30 | 0001213900-16-017105 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-17 | 2025-12-31 | 0001731122-26-000253 | EDGAR | 26K words |
| 2025-11-14 | 2025-09-30 | 0001731122-25-001544 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0001731122-25-000765 | EDGAR | — |
| 2025-02-19 | 2024-12-31 | 0001731122-25-000258 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001731122-24-001811 | EDGAR | — |
| 2024-05-15 | 2024-03-31 | 0001731122-24-000807 | EDGAR | — |
| 2024-02-14 | 2023-12-31 | 0001731122-24-000248 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001731122-23-002120 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001731122-23-000898 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0001731122-23-000326 | EDGAR | — |
| 2023-03-07 | 2022-09-30 | 0001731122-23-000321 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001731122-22-000892 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0001731122-26-000502 | EDGAR | 5K words |
| 2026-03-05 | 0001731122-26-000345 | EDGAR | — |
| 2026-02-23 | 0001731122-26-000282 | EDGAR | — |
| 2026-02-12 | 0001731122-26-000221 | EDGAR | — |
| 2025-12-03 | 0001731122-25-001625 | EDGAR | — |
| 2025-11-25 | 0001731122-25-001597 | EDGAR | — |
| 2025-11-06 | 0001731122-25-001495 | EDGAR | — |
| 2025-11-03 | 0001731122-25-001465 | EDGAR | — |
| 2025-10-30 | 0001731122-25-001446 | EDGAR | — |
| 2025-10-16 | 0001731122-25-001399 | EDGAR | — |
262 total filings indexed. 230 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001527728 |
| Ticker | LNAI |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.renovarogroup.com |
| Listed | 2014-11-18 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report